DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Cohen AT, Boyd RA, Mandema JW, Dicarlo L, Pak R. ; A5571010 Investigators.
An adaptive-design dose-ranging study of PD 0348292, an oral factor Xa inhibitor, for thromboprophylaxis after total knee replacement surgery.
J Thromb Haemost 2013;
11 (08) 1503-1510
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.